SCHEMBL2482008

SCHEMBL2482008

C1CNCC(N2CCOCC2)C1.O=[N+]([O-])c1ccc(N2CCCC(N3CCOCC3)C2)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.45
SIRT6 Q8N6T7 1/20 0.45
MAPT P10636 5/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 2/20 0.43
MAPK1 P28482 1/20 0.43
AKR1C3 P42330 1/20 0.42
CYP1B1 Q16678 1/20 0.41
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
BLM P54132 1/20 0.39
DPP4 P27487 1/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL520213 0.90 MAPT (0.54) ADRB1SIRT6MAPTKMT2AMEN1
SCHEMBL2483651 0.84 MAPT (0.48) ADRB1SIRT6MAPTKMT2AMEN1
SCHEMBL12006741 0.79 MEN1 (0.63) ADRB1SIRT6MAPTKMT2AMEN1
SCHEMBL12005434 0.79 MEN1 (0.63) ADRB1SIRT6MAPTKMT2AMEN1
SCHEMBL12005432 0.79 MEN1 (0.63) ADRB1SIRT6MAPTKMT2AMEN1
SCHEMBL17888637 0.79 AKR1C3 (0.56) ADRB1SIRT6MAPTKMT2AMEN1
SCHEMBL520818 0.77 LMNA (0.63) ADRB1SIRT6MAPTKMT2AMEN1
SCHEMBL30984773 0.77 MEN1 (0.64) ADRB1SIRT6MAPTKMT2AMEN1
SCHEMBL15552714 0.76 KMT2A (0.55) ADRB1SIRT6MAPTKMT2AMEN1
SCHEMBL17645059 0.76 KMT2A (0.55) ADRB1SIRT6MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376491-A1 PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS Cephalon, Inc. (US) 2011-10-19 EP disclosed
WO-2010071885-A1 PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS CEPHALON, INC. (US) 2010-06-24 WO disclosed